Neuroprotective effects of lixisenatide and liraglutide in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinsons disease
Overweight and obesity management: NICE Guideline NG246
doi:10.1016/S0098-2997(01)00013-9 57
[DOI] [PubMed] [Google Scholar] 63.Sardeli A.V., Komatsu T.R., Mori M.A., Gaspari A.F., Chacon-Mikahil M.P.T
Arguments for Overhyped Classification Significant limitations challenge the game changer narrative: Cost and Access Barriers : The high cost and limited insurance coverage create substantial barriers that prevent widespread access, potentially limiting population-level impact despite individual efficacy
Global Burden of Diabetes, 1995-2025: Prevalence, Numerical Estimates, and Projections